Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Gastroenterology|April 1, 1997
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupL R Sutherland, F Martin, R J Bailey, et al.
Gastroenterology|August 1, 1992
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneityF Shanahan, R H Duerr, J I Rotter, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 14, 2000
Prospective study of biliary strictures to determine the predictors of malignancyV G Bain, N Abraham, G S Jhangri, et al.
Gastroenterology|June 1, 1987
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitisL R Sutherland, F Martin, S Greer, et al.
Inflammatory Bowel Diseases|August 29, 2000
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupE J Irvine, G R Greenberg, B G Feagan, et al.
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
Hepatology (Baltimore, Md.)|January 1, 1986
Reticuloendothelial system Fc receptor-mediated clearance of IgG-tagged erythrocytes from the circulation of patients with idiopathic ulcerative colitis and chronic liver diseaseG Y Minuk, N B Hershfield, W Y Lee, et al.
Hepatology (Baltimore, Md.)|January 1, 1985
The Sunnybrook Gallstone Study: a double-blind controlled trial of chenodeoxycholic acid for gallstone dissolutionM M Fisher, E A Roberts, I E Rosen, et al.
Gastroenterology|November 1, 1988
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosisG Y Minuk, C E Bohme, E Burgess, et al.
Pageof 10